Literature DB >> 18254252

The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats.

Sang Kyu Lee1, Sudeep R Bista, Hemin Jeong, Dong Hyeon Kim, Mi Jeong Kang, Yurngdong Jahng, Tae Cheon Jeong.   

Abstract

Rutaecarpine, an alkaloid originally isolated from the unripe fruit of Evodia rutaecarpa, has been shown to be anti-inflammatory as it inhibits cyclooxygenase-2. It induces the activities of hepatic CYP 1A2, 2B, and 2E1 in rats. A possible interaction between rutaecarpine and acetaminophen (APAP) was investigated in male Sprague Dawley rats in the present study. When 25 mg/kg APAP was intravenously administered concurrently with 80 mg/kg rutaecarpine, the area under the curve of APAP in plasma was significantly decreased when compared to that of APAP alone. When the rats were pre-treated orally with 40 and 80 mg/kg rutaecarpine for 3 days, the % value of C(max) and area under the curve of acetaminophen-sulfate conjugate were significantly decreased to 56.4% and 61.7% of the vehicle control group, respectively. These results suggest that rutaecarpine might cause changes in the pharmacokinetic parameters of APAP in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18254252     DOI: 10.1007/bf02977334

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  3 in total

1.  Effects of Oral Rutaecarpine on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats.

Authors:  Sudeep R Bista; Sang Kyu Lee; Dinesh Thapa; Mi Jeong Kang; Young Min Seo; Ju Hyun Kim; Dong Hyeon Kim; Yurngdong Jahng; Jung Ae Kim; Tae Cheon Jeong
Journal:  Toxicol Res       Date:  2008-09-01

Review 2.  Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries.

Authors:  Vidushi S Neergheen-Bhujun
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

3.  Khellin and visnagin differentially modulate AHR signaling and downstream CYP1A activity in human liver cells.

Authors:  Radim Vrzal; Katrin Frauenstein; Peter Proksch; Josef Abel; Zdenek Dvorak; Thomas Haarmann-Stemmann
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.